摘要
目的:评估尼可地尔(Nicoradil)超极化心脏停搏心肌保护的有效性,并与高钾心肌麻痹液去极化心脏停搏的心肌保护效果进行比较。方法:实验分3组,即对照组、去极化心脏停搏组、超极化心脏停搏组。10ml4℃心肌麻痹液诱停离体鼠心,每30min重复灌注心肌麻痹液5ml,在(15±1)℃下心脏停搏120min,再灌注后离体心工作30min。记录心脏机械停搏时间、再灌注后心脏复跳情况、心功能指标恢复(左室发展压、主动脉流量及左室压力微分)、冠状循环灌注平均流量、心肌丙二醛(MDA)含量、电镜下心肌超微结构的改变。结果:超极化心脏停搏组对心功能恢复、冠状循环灌注平均流量及心肌组织超微结构的保护效果优于去极化心脏停搏组(P<0.05),心肌MDA含量低于去极化心脏停搏组(P<0.01)。
Objectives: To evaluate myocardial protective effect of hyperpolarized cardioplegic arrest, its myocardial protective efficiency was compared with traditional depolarized cardiac arrest with St. Thomas No.2 solution in isolated working rat heart. Methods: Twenty four isolated working rat hearts were divided into 3 groups randomly. There were group A: control, group B: depolarized cardiac arrest with St. Thomas solution No.2, group C: hyperpolarized cardiac arrest ( nicorandil 100 μmol/L). The hearts underwent a 120 minute hypothermic arrest (15±1℃) with induction of 10 ml cardioplegia and reinfusion of 5 ml cardioplegia every 30 minutes. Mechanical arrest time, cardiac functional recoveries, myocardial content of malondialdehyde (MDA) and ultrastructure were measured. Results: There were statistically significant differences between B and C group in the recovery of cardiac function, myocardial content of MDA, and ultrastucture of mitochondrial membranes and cristae. Conclusions : The effect of myocardial protection with nicorandil is superior to that with St. Thomas No.2 solution.
出处
《医学研究生学报》
CAS
1999年第1期3-6,共4页
Journal of Medical Postgraduates
基金
国家人事部科研基金A类资助
关键词
尼可地尔
心肌保护
超极化心脏停搏
ATP敏感钾通道开放剂
Nicorandil Myocardial protection Hyperpolarized cardiac arrest ATP sensitive potassium channel opener